Literature DB >> 33669016

Polyphosphorhydrazone-Based Radical Dendrimers.

Vega Lloveras1, José Vidal-Gancedo1.   

Abstract

The search for new biomedical applications of dendrimers has promoted the synthesis of new radical-based molecules. Specifically, obtaining radical dendrimers has opened the door to their use in various fields such as magnetic resonance imaging, as anti-tumor or antioxidant agents, or the possibility of developing new types of devices based on the paramagnetic properties of organic radicals. Herein, we present a mini review of radical dendrimers based on polyphosphorhydrazone, a new type of macromolecule with which, thanks to their versatility, new metal-free contrast agents are being obtained, among other possible applications.

Entities:  

Keywords:  PPH dendrimers; contrast agents; magnetic resonance imaging; organic radicals; radical dendrimers

Mesh:

Substances:

Year:  2021        PMID: 33669016      PMCID: PMC7956296          DOI: 10.3390/molecules26051230

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  28 in total

1.  The dendritic effect illustrated with phosphorus dendrimers.

Authors:  Anne-Marie Caminade; Armelle Ouali; Régis Laurent; Cédric-Olivier Turrin; Jean-Pierre Majoral
Journal:  Chem Soc Rev       Date:  2015-06-21       Impact factor: 54.564

Review 2.  Recent advances in development of dendritic polymer-based nanomedicines for cancer diagnosis.

Authors:  Haonan Li; Jiayu Sun; Hongyan Zhu; Haoxing Wu; Hu Zhang; Zhongwei Gu; Kui Luo
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-09-19

3.  Synthesis and structural characterization of a dendrimer model compound based on a cyclotriphosphazene core with TEMPO radicals as substituents.

Authors:  Elena Badetti; Vega Lloveras; Klaus Wurst; Rosa María Sebastián; Anne-Marie Caminade; Jean-Pierre Majoral; Jaume Veciana; José Vidal-Gancedo
Journal:  Org Lett       Date:  2013-07-05       Impact factor: 6.005

Review 4.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

5.  Nitroxyl radicals-modified dendritic poly(l-lysine) as a contrast agent for Overhauser-enhanced MRI.

Authors:  Takuro Niidome; Risa Gokuden; Kazuto Watanabe; Takeshi Mori; Tatsuya Naganuma; Hideo Utsumi; Kazuhiro Ichikawa; Yoshiki Katayama
Journal:  J Biomater Sci Polym Ed       Date:  2014-08-04       Impact factor: 3.517

6.  Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.

Authors:  Chie Kojima; Baris Turkbey; Mikako Ogawa; Marcelino Bernardo; Celeste A S Regino; L Henry Bryant; Peter L Choyke; Kenji Kono; Hisataka Kobayashi
Journal:  Nanomedicine       Date:  2011-04-08       Impact factor: 5.307

7.  The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.

Authors:  Cyprian Olchowy; Kamil Cebulski; Mateusz Łasecki; Radosław Chaber; Anna Olchowy; Krzysztof Kałwak; Urszula Zaleska-Dorobisz
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

8.  Enhancing the Efficacy of Metal-Free MRI Contrast Agents via Conjugating Nitroxides onto PEGylated Cross-Linked Poly(Carboxylate Ester).

Authors:  Shiwei Guo; Xiaoming Wang; Yan Dai; Xinghang Dai; Zhiqian Li; Qiang Luo; Xiuli Zheng; Zhongwei Gu; Hu Zhang; Qiyong Gong; Kui Luo
Journal:  Adv Sci (Weinh)       Date:  2020-06-03       Impact factor: 16.806

9.  Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.

Authors:  Scott D Swanson; Jolanta F Kukowska-Latallo; Anil K Patri; Chunyan Chen; Song Ge; Zhengyi Cao; Alina Kotlyar; Andrea T East; James R Baker
Journal:  Int J Nanomedicine       Date:  2008
View more
  1 in total

Review 1.  Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature.

Authors:  Badriyah Shadid Alotaibi; Manal Buabeid; Nihal Abdalla Ibrahim; Zelal Jaber Kharaba; Munazza Ijaz; Sobia Noreen; Ghulam Murtaza
Journal:  Int J Nanomedicine       Date:  2021-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.